You're Here: Research Reports » Pharma/Biotech
US OTC Pharmaceutical Market Guide
Single User PDF -
Single User Print -
Global License -
Print order form to pay by check

The US OTC industry is expected to have a market value of $31.9 billion by the end of 2014. In this research report, you’ll learn about the U.S. OTC Pharmaceutical Market’s competitive landscape, market share and industry segmentation in this research report.

The United States is a large market for OTC pharmaceuticals, and it is regulated by the Food and Drug Administration (FDA). While the laws governing OTC pharmaceuticals are very strict, the market itself has grown over the years and has many major players operating in the industry.

With market growth mitigating rivalry in the pharma market, manufacturers are focusing on product differentiation in order to make a niche for themselves. This report includes provides a SWOT analysis and product offerings of major industry players including Bristol Myers Squibb, Novartis, Bayer, GlaxoSmithKline, and many others.

With the global OTC pharmaceuticals industry expected to grow at a moderate pace in the coming years, the U.S. OTC pharmaceuticals market is also looking for a decelerated growth till the year 2014.

This research report on the U.S. OTC Pharmaceutical Market analyzes this high-growth industry’s market value and competitive landscape, and includes a U.S. OTC Drug Monograph.

Pages: 62
Published: November 2012
Publisher: Red Mountain Insights
ISBN: 978-1-62484-003-6
Analysis of the Global OTC Pharmaceuticals Market 6
Market Definition 6
Market Overview 6
Industry Value 7
Industry Segmentation 7
Global Market Share 7
Competitive Landscape 8
Analysis of Market Share 10
Industry Outlook 11
Analysis of the U.S. OTC Pharmaceuticals Market 12
Market Statistics 12
Market Overview 12
Industry Value 14
Industry Segmentation 14
Global Market Share 15
Competitive Landscape 15
Analysis of Market Share 18
OTC Sales 18
OTC Labeling 18
Industry Outlook 20
Institutional Framework for OTC Drugs in the U.S. 21
Overview 21
OTC Drug Product Review 21
Pricing & Reimbursement Policy 22
Promotion to Customers 22
U.S. OTC Drug Monograph 24
Overview 24
What is the OTC Drug Monograph? 24
Using OTC Monograph for Product Launches 25
Analysis through Case Study 26
Conclusion 31
Major Players 32
Bayer AG 32
Bristol-Myers Squibb Company 41
Novartis AG 45
Pfizer Inc 51
Sanofi-Aventis SA 53
Johnson & Johnson 55
GlaxoSmithKline Plc 57
GelStat Corporation 61
Bayer AG
Bristol-Myers Squibb Company
Novartis AG
Pfizer Inc
Sanofi-Aventis SA
Johnson & Johnson
GlaxoSmithKline Plc
GelStat Corporation
Single User PDF -
Single User Print -
Global License -
Print order form to pay by check

Enter email to learn about new product releases

Just Published

Military Microgrids Market Analysis and Project Profiles 2017
This report provides a guide to understanding military microgrids for service and technology providers, government contractors, and military installations This report profiles major smart grids technology and service providers to the military. It acts as a solid start to planning a military microgrid design and installation, providing case studies of existing military microgrid systems. [...]

Internet of Things in Smart Buildings to 2020
This report is an assessment of the market for Internet of Things technologies, networks, and services in buildings to 2020. It details market size and discusses opportunities for smart commercial buildings. We project that the global market for the Internet of Things in Buildings (BIoT) will rise from $22.93Bn in 2014 to over $85Bn in 2020. [...]

Smart Buildings and Wireless Lighting Controls Market to 2018
This report details the market for Wireless lighting Controls market including the competitive landscape, market size, and investment landscape. It analyzes current and future demand for lighting and its control in public, industrial, and commercial buildings. It examines how wireless control can open up the retrofit business, a long-stagnant market. [...]